FDA Approves Groundbreaking Gene Therapy Restoring Hearing in Deaf Children
The FDA has approved Otarmeni, a gene therapy for severe-to-profound hearing loss caused by OTOF gene mutations. Clinical trials showed 80% of treated...
The FDA has approved Otarmeni, a gene therapy for severe-to-profound hearing loss caused by OTOF gene mutations. Clinical trials showed 80% of treated...
A groundbreaking gene therapy from Regeneron Pharmaceuticals restored hearing in 80% of deaf children, including a 18-month-old patient who can now he...
A groundbreaking gene therapy trial in China has demonstrated remarkable success, with 90% of deaf children showing significant hearing improvement. T...